What is Quantum Surgical?
Quantum Surgical, co-founded in France in 2017, is a pioneering entity in the field of medical robotics and artificial intelligence. The company has developed the Epione robotic-assisted platform, a groundbreaking system designed for minimally invasive tumor ablation. This innovative technology aims to transform cancer treatment by offering enhanced precision and patient comfort. Quantum Surgical's mission is to democratize access to cutting-edge cancer care, enabling interventional radiologists worldwide to standardize treatment protocols and improve patient outcomes. The platform has already been utilized in treating hundreds of patients globally, marking a significant step in advancing oncological interventions.
How much funding has Quantum Surgical raised?
Quantum Surgical has raised a total of $68M across 1 funding round:
Private Equity
$68M
Private Equity (2025): $68M, investors not publicly disclosed
What's next for Quantum Surgical?
The recent major strategic investment signals a pivotal growth phase for Quantum Surgical, likely enabling the company to scale its operations, further develop its Epione platform, and expand its market reach. This enterprise-level funding suggests a focus on accelerating commercialization and solidifying its position as a leader in robotic-assisted cancer treatment. Future developments may include broader clinical adoption, integration of enhanced AI capabilities for diagnostic and therapeutic support, and strategic partnerships to broaden access to their advanced medical solutions.
See full Quantum Surgical company page
